Litcius/Paper detail

Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Enrico Maffini, Maud Ngoya, Jacques‐Emmanuel Galimard, Samia Harbi, Nicolaus Kröger, Uwe Platzbecker, Henrik Sengeloev, Charles Craddock, Victoria Potter, Goda Choi, Patrice Chevallier, Friedrich Stölzel, Eleni Tholouli, Johan Maertens, Fabio Ciceri, Jan J. Cornelissen, Jaime Sanz, Alexandros Spyridonidis, Francesco Lanza, Arnon Nagler, Mohamad Mohty

2023Bone Marrow Transplantation19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineMyeloid leukemiaIncidence (geometry)TransplantationLeukemiaAcute leukemiaCumulative incidenceHematopoietic stem cell transplantationClinical trialHematopoietic cellGastroenterologyProspective cohort studySurgeryHaematopoiesisOncologyStem cellOpticsBiologyPhysicsGeneticsHematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchImmune Cell Function and Interaction
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) | Litcius